换一批
换一批KRAS mutant allele-specific imbalance (MASI) assessment in routine samples of patients with metastatic colorectal cancer.
作者：
主题词
等位基因失衡(Allelic Imbalance);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);结直肠肿瘤(Colorectal Neoplasms);DNA突变分析(DNA Mutational Analysis);抗药性, 肿瘤(Drug Resistance, Neoplasm);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);外显子(Exons);疾病遗传易感性(Genetic Predisposition to Disease);人类(Humans);意大利(Italy);Kaplan-Meiers评估(Kaplan-Meier Estimate);突变(Mutation);肿瘤转移(Neoplasm Metastasis);病人遴选(Patient Selection);表型(Phenotype);试验预期值(Predictive Value of Tests);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质类(Proto-Oncogene Proteins);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));时间因素(Time Factors);转染(Transfection);治疗结果(Treatment Outcome);ras蛋白质类(ras Proteins)
DOI
10.1136/jclinpath-2014-202761
PMID
25609577
发布时间
2018-12-02
- 浏览50
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
